(19)
(11) EP 4 798 183 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24808484.0

(22) Date of filing: 23.10.2024
(51) International Patent Classification (IPC): 
A61K 31/192(2006.01)
A61P 25/28(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/192; A61P 25/28
(86) International application number:
PCT/US2024/052535
(87) International publication number:
WO 2025/090587 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 23.10.2023 US 202363545361 P
02.04.2024 US 202463573398 P

(71) Applicant: Inmed Pharmaceuticals Inc.
Vancouver, British Columbia V6C 1B4 (CA)

(72) Inventors:
  • HSU, Eric, C.
    Vancouver, BC V6C 1B4 (CA)
  • KEALEY, James, T.
    Vancouver, BC V6C 1B4 (CA)
  • SOMVANSHI, Rishi, K.
    Vancouver, BC V6C 1B4 (CA)
  • KUMAR, Ujendra
    Vancouver, BC V6C 1B4 (CA)

(74) Representative: Secerna LLP 
The Old Fire Station 18 Clifford Street
York YO1 9RD
York YO1 9RD (GB)

   


(54) CANNABINOIDS COMPOUNDS AND THEIR USE IN THE TREATMENT OF NEURONAL DISORDERS